Food Effect and Mass Balance Study of XZP-3621 Tablets

Summary

This is a single-center, open-label, single-dose phase I study, the study is divided into two stages. The stage 1 is to investigate the absorption, metabolism and excretion of XZP-3621 tablets in healthy Chinese subjects. The stage 2 is to evaluate the effect of food on the Pharmacokinetics of single-dose XZP-3621 tablets in Chinese Healthy Volunteers. In addition, the safety of XZP-3621 tablets in Chinese Healthy Volunteers will also be evaluated.

Timeline

Start

2021-12-23

Primary completion

2022-03-30

Completion

2022-03-30

Drugs

Indications

No indication recorded.